AxoGen, Inc. (AXGN) vs Neogen Corporation (NEOG)
AxoGen, Inc. and Neogen Corporation are both Medical Devices companies. Neogen Corporation is the larger, with a market value of $3.0B against $2.5B — 1.2× the size. AxoGen, Inc. grew revenue faster over the last twelve months: 23.6% against −2.72%. Neogen Corporation has the higher net margin (−0.91% vs −13.4%) and the higher return on invested capital (−0.50% vs −4.99%). Across the 19 metrics below, Neogen Corporation leads on 14 and AxoGen, Inc. on 5.
Valuation
Profitability
| Metric | AXGN | NEOG | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.56% | 46.93% | 56.01% |
| Operating margin | (5.12%) | (2.48%) | (15.03%) |
| Net margin | (13.36%) | (0.91%) | (20.40%) |
| Free cash flow margin | 2.59% | 3.68% | (7.24%) |
| Return on equity | (18.21%) | (0.38%) | (15.32%) |
| Return on assets | (13.15%) | (0.23%) | (19.72%) |
| Return on invested capital | (4.99%) | (0.50%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack